Release kinetics and cancer cell cytotoxicity of quercetin from polymer coated deformable lipid-based nanocarriers
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · Advancements in Transdermal Drug Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Jan AT, Kamli MR, Murtaza I, Singh JB, Ali A, Haq QMR (2010) Dietary flavonoid quercetin and associated health benefits—an overview. Food Rev Int 26:302–317. https://doi.org/10.1080/87559129.2010.48428510.1080/87559129.2010.484285 ↗
2. Li Y, Yao J, Han C, Yang J, Chaudhry M, Wang S, Liu H, Yin Y (2016) Quercetin, inflammation and immunity. Nutrients 8:167. https://doi.org/10.3390/nu803016710.3390/nu8030167 ↗
3. Singh P, Arif Y, Bajguz A, Hayat S (2021) The role of quercetin in plants. Plant Physiol Biochem 166:10–19. https://doi.org/10.1016/j.plaphy.2021.05.02310.1016/j.plaphy.2021.05.023 ↗
4. Rogerio AP, Dora CL, Andrade EL, Chaves JS, Silva LFC, Lemos-Senna E, Calixto JB (2010) Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol Res 61:288–297. https://doi.org/10.1016/j.phrs.2009.10.00510.1016/j.phrs.2009.10.005 ↗
5. Oh WY, Ambigaipalan P, Shahidi F (2021) Quercetin and its ester derivatives inhibit oxidation of food, LDL and DNA. Food Chem 364:130394. https://doi.org/10.1016/j.foodchem.2021.13039410.1016/j.foodchem.2021.130394 ↗
6. Ghosh A, Ghosh D, Sarkar S, Mandal AK, Thakur Choudhury S, Das N (2012) Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats. Eur J Cancer Prev 21:32–41. https://doi.org/10.1097/CEJ.0b013e32834a7e2b10.1097/CEJ.0b013e32834a7e2b ↗
7. Lozano O, Solis-Castañol D, Cantú-Casas S, Mendoza Muraira PI, García-Rivas G (2023) A review of quercetin delivery through nanovectors: cellular and mitochondrial effects on noncommunicable diseases. Molecular Nutrition and Mitochondria. Elsevier, pp 363–38210.1016/B978-0-323-90256-4.00006-0 ↗
8. Chen X, Yin OQP, Zuo Z, Chow MSS (2005) Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 22:892–901. https://doi.org/10.1007/s11095-005-4584-110.1007/s11095-005-4584-1 ↗
9. Huang R, Xu C (2021) An overview of the perception and mitigation of astringency associated with phenolic compounds. Compr Rev Food Sci Food Saf 20:1036–1074. https://doi.org/10.1111/1541-4337.1267910.1111/1541-4337.12679 ↗
10. Chen Y-Q, Chen H-Y, Tang Q-Q, Li Y-F, Liu X-S, Lu F-H, Gu Y-Y (2022) Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines. Front Pharmacol. https://doi.org/10.3389/fphar.2022.96822610.3389/fphar.2022.968226 ↗
11. Bai C, Hu X, Lu S, Xu B, Song Y, Hu X, Lu S, Xu B, Song Y (2025) Recent advances and application challenges of quercetin-loaded delivery systems from material selection to bioavailability. 0–37. https://doi.org/10.1016/j.jfutfo.2025.01.01410.1016/j.jfutfo.2025.01.014 ↗
12. Egert S, Wolffram S, Bosy-westphal A, Boesch-saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans 1, 2. J Nutr 138:1615–1621. https://doi.org/10.1093/jn/138.9.161510.1093/jn/138.9.1615 ↗
13. Targeting E, At E, Tissue THE, Levels C, The I, Of D, Barriers T (2023). The future of drug delivery. https://doi.org/10.1021/acs.chemmater.2c0300310.1021/acs.chemmater.2c03003 ↗
14. Sharma S, Kumar A, Kumar R, Jay R, Abhinav S, Amulya G (2025) Quercetin - loaded self - nanoemulsifying systems: lipid carrier effects on phase behaviour, release, and cellular impacts. Bionanoscience. https://doi.org/10.1007/s12668-025-02083-210.1007/s12668-025-02083-2 ↗
15. Pratap Singh A, Dinesh P, Chauhan I, Jindal A, Kumar J, Kumar N, Verma M, Yasir M, Antal S, Dhiman P, Saxena Kumar P (2025) Modulation of anti-inflammatory activity via diclofenac sodium-based nanostructured-lipid carriers: physical characterization and in vivo assessment. Assay Drug Dev Technol 15. https://doi.org/10.1089/adt.2025.00410.1089/adt.2025.004 ↗
16. Ferreira-Silva M, Faria-Silva C, Carvalheiro MC, Simões S, Marinho HS, Marcelino P, Campos MC, Metselaar JM, Fernandes E, Baptista PV, Fernandes AR, Corvo ML (2022) Quercetin liposomal nanoformulation for ischemia and reperfusion injury treatment. Pharmaceutics 14:104. https://doi.org/10.3390/pharmaceutics1401010410.3390/pharmaceutics14010104 ↗
17. Censi R, Martena V, Hoti E, Malaj L, Di Martino P (2012) Permeation and skin retention of quercetin from microemulsions containing Transcutol ® P. Drug Dev Ind Pharm 38:1128–1133. https://doi.org/10.3109/03639045.2011.64156410.3109/03639045.2011.641564 ↗
18. Lozano O, Lázaro-Alfaro A, Silva-Platas C, Oropeza-Almazán Y, Torres-Quintanilla A, Bernal-Ramírez J, Alves-Figueiredo H, García-Rivas G (2019) Nanoencapsulated quercetin improves cardioprotection during hypoxia-reoxygenation injury through preservation of mitochondrial function. Oxid Med Cell Longev. https://doi.org/10.1155/2019/768305110.1155/2019/7683051 ↗
19. Agiba AM, Rodríguez Huerta LG, Ulloa-Castillo NA, Sierra-Valdez FJ, Beigi-Boroujeni S, Lozano O, Aguirre-Soto A (2025) Fusion of polymer-coated liposomes and centrifugally spun microfibers as hybrid materials to enhance sustained release. Nanoscale Adv 7:1009–1017. https://doi.org/10.1039/D4NA00835A10.1039/D4NA00835A ↗
20. Keshavarz F, Dorfaki M, Bardania H, Khosravani F, Nazari P, Ghalamfarsa G (2023) Quercetin-loaded liposomes effectively induced apoptosis and decreased the epidermal growth factor receptor expression in colorectal cancer cells: an in vitro study. Iran J Med Sci 48:321–328. https://doi.org/10.30476/IJMS.2022.95272.265810.30476/IJMS.2022.95272.2658 ↗
21. Peetla C, Stine A, Labhasetwar V (2009) Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm. https://doi.org/10.1021/mp900066210.1021/mp9000662 ↗
22. Li Y, Wang J, Gao Y, Zhu J, Wientjes MG, Au JL (2011) Relationships between liposome properties , cell membrane binding , intracellular processing , and intracellular bioavailability. AAPS J. https://doi.org/10.1208/s12248-011-9298-110.1208/s12248-011-9298-1 ↗
23. Gandek TB, Koog LVD, Nagelkerke A (2023) A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles. Adv Healthc Mater 12:1–33. https://doi.org/10.1002/adhm.20230031910.1002/adhm.202300319 ↗
24. Harmon AM, Lash MH, Sparks SM, Uhrich KE (2011) Preferential cellular uptake of amphiphilic macromolecule-lipid complexes with enhanced stability and biocompatibility. J Control Release 153:233–239. https://doi.org/10.1016/j.jconrel.2011.04.00410.1016/j.jconrel.2011.04.004 ↗
25. Wong M-Y, Chiu GNC (2010) Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. Anticancer Drugs 21:401–410. https://doi.org/10.1097/CAD.0b013e328336e94010.1097/CAD.0b013e328336e940 ↗
26. Patel G, Thakur NS, Kushwah V, Patil MD, Nile SH, Jain S, Banerjee UC, Kai G (2020) Liposomal delivery of mycophenolic acid with quercetin for improved breast cancer therapy in SD rats. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2020.0063110.3389/fbioe.2020.00631 ↗
27. Saraswat AL, Maher TJ (2020) Development and optimization of stealth liposomal system for enhanced in vitro cytotoxic effect of quercetin. J Drug Deliv Sci Technol 55:101477. https://doi.org/10.1016/j.jddst.2019.10147710.1016/j.jddst.2019.101477 ↗
28. Kruszewski M, Kusaczuk M, Kotyńska J, Gál M, Krętowski R, Cechowska-Pasko M, Naumowicz M (2018) The effect of quercetin on the electrical properties of model lipid membranes and human glioblastoma cells. Bioelectrochemistry 124:133–141. https://doi.org/10.1016/j.bioelechem.2018.07.01010.1016/j.bioelechem.2018.07.010 ↗
29. Riaz MK, Zhang X, Wong KH, Chen H, Liu Q, Chen X, Zhang G, Lu A, Yang Z (2019) Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. Int J Nanomedicine 14:2879–2902. https://doi.org/10.2147/IJN.S19221910.2147/IJN.S192219 ↗
30. Long Q, Xie Y, Huang Y, Wu Q, Zhang H, Xiong S, Liu Y, Chen L, Wei Y, Zhao X, Gong C (2013) Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. J Biomed Nanotechnol 9:965–975. https://doi.org/10.1166/jbn.2013.159610.1166/jbn.2013.1596 ↗
31. Hatahet T, Morille M, Hommoss A, Devoisselle JM, Müller RH, Bégu S (2018) Liposomes, lipid nanocapsules and smartcrystals®: a comparative study for an effective quercetin delivery to the skin. Int J Pharm 542:176–185. https://doi.org/10.1016/j.ijpharm.2018.03.01910.1016/j.ijpharm.2018.03.019 ↗
32. Pradhan A, Kumari A, Srivastava R, Panda D (2019) Quercetin encapsulated biodegradable plasmonic nanoparticles for photothermal therapy of hepatocellular carcinoma cells. ACS Appl Bio Mater 2:5727–5738. https://doi.org/10.1021/acsabm.9b0076410.1021/acsabm.9b00764 ↗
33. Manzoor MF, Hussain A, Sameen A, Sahar A, Khan S, Siddique R, Aadil RM, Xu B (2021) Novel extraction, rapid assessment and bioavailability improvement of quercetin: a review. Ultrason Sonochem 78:105686. https://doi.org/10.1016/j.ultsonch.2021.10568610.1016/j.ultsonch.2021.105686 ↗
34. Zhang ZJ, Michniak-kohn B (2020) Flavosomes, novel deformable liposomes for the co-delivery of anti- in fl ammatory compounds to skin. Int J Pharm 585:119500. https://doi.org/10.1016/j.ijpharm.2020.11950010.1016/j.ijpharm.2020.119500 ↗
35. Beg S, Swain S, Rizwan M, Irfanuddin M, Shobha Malini D (2011) Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations. Curr Drug Deliv 8:691–702. https://doi.org/10.2174/15672011179763550410.2174/156720111797635504 ↗
36. Xu L, Shang Z, Liu D, Zhao C, Zhao C, Pei X, Zhang Z (2025) Preparation , characterization and efficacy of hyaluronic acid-modified two targeted liposomes for ectoin delivery to the skin. Colloids Surf A Physicochem Eng Asp. https://doi.org/10.1016/j.colsurfa.2025.13701310.1016/j.colsurfa.2025.137013 ↗
37. Caddeo C, Díez-Sales O, Pons R, Carbone C, Ennas G, Puglisi G, Fadda AM, Manconi M (2016) Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin. J Colloid Interface Sci 461:69–78. https://doi.org/10.1016/j.jcis.2015.09.01310.1016/j.jcis.2015.09.013 ↗
38. Thuy Trang Le N, Nguyen-Huu A-M, Hai Nguyen D, Khoa Nguyen C (2024) Advancing liposomal coating approaches for improved anticancer drug delivery. Chempluschem 90:e20240060010.1002/cplu.202400600 ↗
39. Hao J, Guo B, Yu S, Zhang W, Zhang D, Wang J, Wang Y (2017) Encapsulation of the flavonoid quercetin with chitosan-coated nano-liposomes. LWT-Food Sci Technol 85:37–44. https://doi.org/10.1016/j.lwt.2017.06.04810.1016/j.lwt.2017.06.048 ↗
40. Zhao L, Xiong H, Peng H, Wang Q, Han D, Bai C, Liu Y, Shi S, Deng B (2011) PEG-coated lyophilized proliposomes: preparation, characterizations and in vitro release evaluation of vitamin E. Eur Food Res Technol 232:647–654. https://doi.org/10.1007/s00217-011-1429-510.1007/s00217-011-1429-5 ↗
41. Thomas JA, Abraham S, Raju SP, Das C, Abraham A, Varghese SA, Abraham E (2021) Formulation and evaluation of anti-arthritis drug loaded stealth liposomes. Res J Pharm Technol 14:1313–1318. https://doi.org/10.5958/0974-360X.2021.00233.X10.5958/0974-360X.2021.00233.X ↗
42. Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y (2006) Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J Liposome Res 16:127–141. https://doi.org/10.1080/0898210060068081610.1080/08982100600680816 ↗
43. Jangde R, Singh D (2016) Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artif Cells Nanomed Biotechnol 44:635–641. https://doi.org/10.3109/21691401.2014.97523810.3109/21691401.2014.975238 ↗
44. Kurakula M, Srinivas C, Kasturi N, Diwan P V. (2012) Formulation and evaluation of prednisolone proliposomal gel for effective topical pharmacotherapy. Int J Pharm Sci Drug Res 35–43. https://doi.org/10.25004/IJPSDR.2012.04010710.25004/IJPSDR.2012.040107 ↗
45. Li J, Li Z, Gao Y, Liu S, Li K, Wang S, Gao L, Shi M, Liu Z, Han Z, Qiu Y (2021) Effect of a drug delivery system made of quercetin formulated into PEGylation liposomes on cervical carcinoma in vitro and in vivo. J Nanomater 2021:1–12. https://doi.org/10.1155/2021/938993410.1155/2021/9389934 ↗
46. Jagwani S, Jalalpure S, Dhamecha D, Jadhav K, Bohara R (2020) Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma. ACS Biomater Sci Eng 6:4969–4984. https://doi.org/10.1021/acsbiomaterials.0c0042910.1021/acsbiomaterials.0c00429 ↗
47. Demirbolat GM, Erdoğan Ö, Coşkun GP, Çevik Ö (2022) PEG4000 modified liposomes enhance the solubility of quercetin and improve the liposome functionality: in vitro characterization and the cellular efficacy. Turk J Chem 46:1011–1023. https://doi.org/10.55730/1300-0527.341110.55730/1300-0527.3411 ↗
48. Ren Y, Yi W, Gao J, Wang N, Zhuang D (2025) Correction: TPP-coated Mo-doped W18O49 biodegradable nanomaterials with mitochondriatargeting and pH-responsive properties for synergistic photothermal therapy/chemodynamic therapy/chemotherapy. Biomater Sci 7:10049. https://doi.org/10.1039/d5bm90089a10.1039/d5bm90089a ↗
49. Sun J, Song Y, Lu M, Lin X, Liu Y, Zhou S, Su Y, Deng Y (2016) Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid–octadecylamine conjugate. Eur J Pharm Sci 93:177–183. https://doi.org/10.1016/j.ejps.2016.08.02910.1016/j.ejps.2016.08.029 ↗
50. Anabousi S, Laue M, Lehr C-M, Bakowsky U, Ehrhardt C (2005) Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. Eur J Pharm Biopharm 60:295–303. https://doi.org/10.1016/j.ejpb.2004.12.00910.1016/j.ejpb.2004.12.009 ↗
51. Quagliariello V, Masarone M, Armenia E, Giudice A, Barbarisi M, Caraglia M, Barbarisi A, Persico M (2018) Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells. Oncol Rep. https://doi.org/10.3892/or.2018.693210.3892/or.2018.6932 ↗
52. Lin Z, Deng T, Liu Y, Zheng S, Wang G, He H, Zhang J (2023) Comprehensive analysis of the influence of physicochemical properties and tumor-associated environments on liposome intratumoral penetration. J Control Release 359:33–51. https://doi.org/10.1016/j.jconrel.2023.05.02710.1016/j.jconrel.2023.05.027 ↗
53. Demirbolat GM, Altintas L, Yilmaz S, Degim IT (2018) Development of orally applicable, combinatorial drug–loaded nanoparticles for the treatment of fibrosarcoma. J Pharm Sci 107:1398–1407. https://doi.org/10.1016/j.xphs.2018.01.00610.1016/j.xphs.2018.01.006 ↗
54. Selvamani V (2019) Stability studies on nanomaterials used in drugs. Elsevier Inc10.1016/B978-0-12-814031-4.00015-5 ↗
55. Shao P, Wang P, Niu B, Kang J (2018) Environmental stress stability of pectin-stabilized resveratrol liposomes with different degree of esterification. Int J Biol Macromol 119:53–59. https://doi.org/10.1016/j.ijbiomac.2018.07.13910.1016/j.ijbiomac.2018.07.139 ↗
56. Sheskey PJ, Hancock BC, Goldfarb DJ, Moss GP (2020) Handbook of pharmaceutical excipients, 9th ed. Pharmaceutical Press
57. Ullmann K, Leneweit G, Nirschl H (2021) How to achieve high encapsulation efficiencies for macromolecular and sensitive APIs in liposomes. Pharmaceutics 13:691. https://doi.org/10.3390/pharmaceutics1305069110.3390/pharmaceutics13050691 ↗
58. Vyas SP, Subhedar R, Jain S (2006) Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol 58:321–326. https://doi.org/10.1211/jpp.58.3.000510.1211/jpp.58.3.0005 ↗
59. Liu W, Guo R (2006) Interaction between flavonoid, quercetin and surfactant aggregates with different charges. J Colloid Interface Sci 302:625–632. https://doi.org/10.1016/j.jcis.2006.06.04510.1016/j.jcis.2006.06.045 ↗
60. Gang W, Jie WJ, Ping ZL, Ming DS, Ying LJ, Lei W, Fang Y (2012) Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin Drug Deliv 9:599–613. https://doi.org/10.1517/17425247.2012.67992610.1517/17425247.2012.679926 ↗
61. Hasibi F, Nasirpour A, García-manrique P, Varshosaz J, Guti G, Alvarez-garcía S, Blanco-l MC, Matos M (2024) Effects of thermal processing and pH on the physicochemical properties , stability , and structure of taxifolin-loaded nanostructured lipid carriers. 4:. https://doi.org/10.1016/j.afres.2024.10056310.1016/j.afres.2024.100563 ↗
62. Zhang X, Lin Y, Gillies RJ (2010) Tumor pH and its measurement. J Nucl Med. https://doi.org/10.2967/jnumed.109.06898110.2967/jnumed.109.068981 ↗
63. Siepmann J, Siepmann F (2008) Mathematical modeling of drug delivery. Int J Pharm 364:328–343. https://doi.org/10.1016/j.ijpharm.2008.09.00410.1016/j.ijpharm.2008.09.004 ↗
64. Cell H, Hepg L, Bele A (2006) Quercetin induces apoptosis via caspase activation , regulation of Bcl-2 , and inhibition of PI-3-kinase / Akt and ERK pathways in a human. 2715–2721. https://doi.org/10.1093/jn/136.11.271510.1093/jn/136.11.2715 ↗
65. Chang C, Han D, Ji Y, Wang M, Li D, Xu Z, Li J, Huang S, Zhu X, Jia Y (2023) Folate-chitosan coated quercetin liposomes for targeted cancer therapy. Curr Pharm Biotechnol 25:924–935. https://doi.org/10.2174/011389201026447923100604501410.2174/0113892010264479231006045014 ↗
66. Liu X, Zhang Y, Liu L, Pan Y, Hu Y, Yang P, Liao M (2020) Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats 5:1–7
67. Jindal A, Kumar Sharma P, Kumar A (2025) Self-nanoemulsifying drug delivery system (SNEDDS) as nano-carrier framework for permeability modulating approaches of BCS class III drug. J Drug Target 33:. https://doi.org/10.1080/1061186X.2025.246975110.1080/1061186X.2025.2469751 ↗
68. Tomar D, Mainuddin, Anshika, Jindal A (2025) Nano-cocrystals as nanotechnology-based approach to modulate solubility and bioavailability of poorly soluble drugs. Curr Top Med Chem 25:. https://doi.org/10.2174/011568026637974325071718152610.2174/0115680266379743250717181526 ↗